NAMI Ask the Expert Webinar welcomes Robert O. Cotes, M.D., Director of the Clinical & Research Program for Psychosis at Grady Health, Emory University School of Medicine, who discusses the unique and potentially life-changing benefits of clozapine, an antipsychotic medication used to treat symptoms of schizophrenia.
Currently, the American Psychiatric Association guidelines recommend a trial of clozapine if a person still has symptoms despite two prior trials of other antipsychotic medications. However, despite its effectiveness, clozapine is underutilized in the U.S. and often treated as a “last resort” option.
In this presentation, Dr. Cotes helps individuals and families better understand clozapine’s benefits, side effects and recent changes to the FDA’s Risk Evaluation and Mitigation Strategy regarding the drug.